Search results

Page results

• Research seeking greater understanding of rare blood cancer and how to treat it

  A new research study at UCLH and UCL will investigate how a rare type of blood cancer develops and what types of treatment may be effective for patients.

• National leadership award for UCLH research practitioner

  UCLH research manager Sarah Taylor has won a national leadership award for her work to develop and train research staff.

• Royal National Orthopaedic Hospital joins UCLH on Epic electronic health record

  On Sunday 23 November, the Royal National Orthopaedic Hospital (RNOH) successfully connected to UCLH’s Epic electronic health record (EHR). This is another milestone in our collaboration and digital transformation across North Central London.

• National dementia research role for UCLH clinician

  UCLH consultant neurologist Dr Catherine Mummery has been announced as the new Chair of the NIHR Dementia Translational Research Collaboration.

• Bronchial Artery Embolisation (BAE)

  This page tells you about the procedure known as a Bronchial Artery Embolisation (BAE).

• Thoracic Surgery – Information for patients: Having a thymectomy procedure

  Patient information for patients having a thymectomy procedure.

• Thoracic Surgery – Information for patients: Having surgery via median sternotomy

  Information for patients having a surgery via median sternotomy.

• Thoracic Surgery – Information for patients: Having a mediastinoscopy / mediastinotomy procedure

  Information for patients having a mediastinoscopy / mediastinotomy procedure.

• National Hospital for Neurology and Neurosurgery anaesthetists rewarded for high-quality patient care

  The National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH NHS Foundation Trust, has been reaccredited under the prestigious Royal College of Anaesthetists (RCoA) Anaesthesia Clinical Services Accreditation (ACSA) demonstrating the hospital anaesthetists’ commitment to patient safety and excellence of care.

• Blood cancer patients to get new cutting-edge treatment on the NHS

  Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.